A combined in vivo study on mouse models and publicly available human datasets regarding tumor LDLR expression concluded that high levels of circulating LDL-C and high cellular LDLR expression in cancer cells were associated with high proliferation of estrogen receptor-positive breast cancer cells [15]. The gene discussed is LDLR; the disease is breast cancer.